Linking immunity to atherosclerosis: Implications for vascular pharmacology - A tribute to Goran K. Hansson
2012 (English)In: Vascular pharmacology, ISSN 1537-1891, E-ISSN 1879-3649, Vol. 56, no 1-2, 29-33 p.Article, review/survey (Refereed) Published
For the past decade, we have deepened our understanding of the pathogenesis of atherosclerosis, a chronic arterial disease that causes cardiac and cerebral infarction and peripheral vascular disorders. Because of this extended understanding, more effective strategies for prevention and treatment of this disease are emerging. One of the fundamental mechanisms that lead to progress or regression in atherosclerosis, thus influencing its life-threatening complications, occurs through functional changes in vascular immunity and inflammation. This review briefly summarizes the discoveries in basic and translational sciences in this area and recent advances in clinical medicine against atherosclerotic vascular diseases.
Place, publisher, year, edition, pages
Elsevier , 2012. Vol. 56, no 1-2, 29-33 p.
Atherosclerosis, Immunity, Inflammation, Macrophages, Lymphocytes, Antibody, Immunotherapy
Medical and Health Sciences
IdentifiersURN: urn:nbn:se:liu:diva-75473DOI: 10.1016/j.vph.2011.11.001ISI: 000300121400005OAI: oai:DiVA.org:liu-75473DiVA: diva2:507078
Funding Agencies|National Institutes of Health||Texas State Higher Education Board||Swedish Research Council||Swedish Heart-Lung Foundation||2012-03-022012-03-022012-03-02